Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5).
Détails
ID Serval
serval:BIB_DFCBD78709DD
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5).
Périodique
JAMA Pediatrics
Collaborateur⸱rice⸱s
MACS-5 Collaborative Group
Contributeur⸱rice⸱s
Asztalos EV., Murphy K., Willan A., Matthews S., Hannah M., Ohlsson A., Kelly E., Saigal S., Ross S., Delisle M., Amankwah K., Guselle P., Gafni A., Lee S., Armson B., Sananes R., Rovet J., Sanchez J., Saleem M., Asztalos E., Murphy K., Saigal S., Bracken M., Crowley P., Thorpe K., Duley L., Erenkranz R., Kavuma E., Saleem M., Tobin S., Shi M., Chan S., Gubatan J., Cardwell J., Leung M., Sanchez J., Mason D., Kwiatkowski L., Deguer C., Salazar A., Brindo M., Klun M., Castaldi JL., Bertin MS., Rodriguez D., Fustiñana CA., Otaño L., Izbizky G., Palermo MS., Varela DM., García£££María Valeria£££ MV. , Trasmonte ME., Basualdo MN., Schapira I., Andina E., Di Marco I., Aspres N., Rivero M., Gomez EE., Palacios LL., Ahlbom MB., Bonassies MS., Vidal DA., Aguirre JD., Morales EM., Garcia SA., Abreo GI., De Sagastizabal MT. , Martin Rde L., De Gaetano SL. , Walter M., Arias C., Farri ML., Gorostiaga RA., Alvarado JE., Curioni M., Tessari DM., Madi JM., Zatti H., Mattana Mdo C., Ártico Gl., Trapani A.<Suffix>Jr</Suffix> , Finger TC., Rosado£££Luiza Emylce Pelᣣ£ LE. , Teixeira VR., Vidal AC., de Souza GR. , de Sa RA. , Bornia RG., Hendson L., Tomlinson J., Demianczuk N., Penttinen E., Krishnaswamy R., Paquin J., Butt K., Hay K., Beaney A., Armson A., Allen V., Fanning C., Kulkarni R., Laplante J., Carson GD., Williams S., Olatunbosun F., Henry A., Wonko N., Moutquin JM., Ferretti E., Royer D., Blouin D., Bédard SK., Murphy K., Ohlsson A., Kelly E., Rovet J., Sananes R., Asztalos E., Cohen H., Barrett J., Hohn D., Lacy M., Delisle MF., Quelch S., Willar T., Synnes A., Butt A., Hubber-Richard P., Moddemann D., Cote D., Kenny-Lodewyks D., Helewa M., del Rio S., Gomez R., Neculman KS., Vargas P., Pons A., Kusanovic JP., Veloso PP., Aguilera LS., Schifferli MT., Gonzalez PU., Poblete JF., Ferrand P., Reyes AB., Moore R., Belmar C., Ortiz EI., Munoz JT., Sanchez A., Jimenez CA., Atencia D., Hvidman L., Mouritzen A., Vikre-Jørgensen J., Nonnenmacher A., Hopp H., Hoyme UB., Bittrich HJ., Oletzky B., Dressler F., Hollwitz B., Korausova J., Krause M., Petermoeller M., Mueller K., Major£££Tamás£££ T. , Bartha T., Krasznai£££Zoárd£££ Z. , Nachum Z., Faranesh R., Galil A., Hallak M., Adiva H., Harel L., Chayen B., Wolff L., Samberg I., Gonen R., Wolfson E., Kohelet D., Shochot R., Arbel E., Sadan O., Regev R., Zausmer J., Kaneti H., Rosen D., Netter T., Klinger G., Tirosh£££Na'ama£££ N. , Naor N., Maman M., El-Zibdeh M., Al-Faris L., Preis K., Domzalska-Popadiuk I., Thrun A., Kobiela P., Swiatkowska-Freund M., Preis-Ortikowska J., Janczewska I., Kesiak M., Krekora M., Zych K., Wilczynski J., Gulczyńska E., Krasomski G., Breborowicz G., Szymankiewicz M., Rozycka J., Montgomery A., Ropacka M., Madejczyk M., Samsonova T., Malyshkina A., Borzova N., Chasha T., Khodzhaeva Z., Vikhlyaeva E., Grande M., Botet F., Palacio M., Weber P., Tillmann B., Hosli I., Forcada-Guex M., Hohlfeld P., Prince-dit-Clottu E., Belhia F., Roumen FJ., Gavilanes AW., Smits F., Bolaji I.
ISSN
2168-6211 (Electronic)
ISSN-L
2168-6203
Statut éditorial
Publié
Date de publication
2013
Volume
167
Numéro
12
Pages
1102-1110
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Résumé
IMPORTANCE: A single course of antenatal corticosteroid therapy is recommended for pregnant women at risk of preterm birth between 24 and 33 weeks' gestational age. However, 50% of women remain pregnant 7 to 14 days later, leading to the question of whether additional courses should be given to women remaining at risk for preterm birth. The Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS) was an international randomized clinical trial that compared multiple courses of antenatal corticosteroids with a single course in women at risk of preterm birth.
OBJECTIVE: To determine the effects of single vs multiple courses of antenatal corticosteroid therapy on death or neurodevelopmental disability (neuromotor, neurosensory, or neurocognitive/neurobehavioral function) at 5 years of age in children whose mothers participated in MACS. Our secondary aims were to determine the effect on height, weight, head circumference, blood pressure, intelligence, and specific cognitive (visual, spatial, and language) skills.
DESIGN, SETTING, AND PARTICIPANTS: Cohort follow-up study of children seen between June 2006 and May 2012 at 55 centers. In total, 1724 women (2141 children) were eligible for the study, of whom 1728 children (80.7% of the 2141 eligible children) participated and 1719 children contributed to the primary outcome.
INTERVENTION: Single and multiple courses of antenatal corticosteroid therapy.
MAIN OUTCOMES AND MEASURES: The primary outcome was death or survival with a neurodevelopmental disability in 1 of the following domains: neuromotor (nonambulatory cerebral palsy), neurosensory (blindness, deafness, or need for visual/hearing aids), or neurocognitive/neurobehavioral function (abnormal attention, memory, or behavior).
RESULTS: There was no significant difference between the groups in the risk of death or neurodevelopmental disability: 217 of 871 children (24.9%) in the multiple-courses group vs 210 of 848 children (24.8%) in the single-course group (odds ratio, 1.02 [95% CI, 0.81 to 1.29]; P = .84).
CONCLUSIONS AND RELEVANCE: Multiple courses, compared with a single course, of antenatal corticosteroid therapy did not increase or decrease the risk of death or disability at 5 years of age. Because of a lack of strong conclusive evidence of short-term or long-term benefits, it remains our opinion that multiple courses not be recommended in women with ongoing risk of preterm birth.
TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00187382.
OBJECTIVE: To determine the effects of single vs multiple courses of antenatal corticosteroid therapy on death or neurodevelopmental disability (neuromotor, neurosensory, or neurocognitive/neurobehavioral function) at 5 years of age in children whose mothers participated in MACS. Our secondary aims were to determine the effect on height, weight, head circumference, blood pressure, intelligence, and specific cognitive (visual, spatial, and language) skills.
DESIGN, SETTING, AND PARTICIPANTS: Cohort follow-up study of children seen between June 2006 and May 2012 at 55 centers. In total, 1724 women (2141 children) were eligible for the study, of whom 1728 children (80.7% of the 2141 eligible children) participated and 1719 children contributed to the primary outcome.
INTERVENTION: Single and multiple courses of antenatal corticosteroid therapy.
MAIN OUTCOMES AND MEASURES: The primary outcome was death or survival with a neurodevelopmental disability in 1 of the following domains: neuromotor (nonambulatory cerebral palsy), neurosensory (blindness, deafness, or need for visual/hearing aids), or neurocognitive/neurobehavioral function (abnormal attention, memory, or behavior).
RESULTS: There was no significant difference between the groups in the risk of death or neurodevelopmental disability: 217 of 871 children (24.9%) in the multiple-courses group vs 210 of 848 children (24.8%) in the single-course group (odds ratio, 1.02 [95% CI, 0.81 to 1.29]; P = .84).
CONCLUSIONS AND RELEVANCE: Multiple courses, compared with a single course, of antenatal corticosteroid therapy did not increase or decrease the risk of death or disability at 5 years of age. Because of a lack of strong conclusive evidence of short-term or long-term benefits, it remains our opinion that multiple courses not be recommended in women with ongoing risk of preterm birth.
TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00187382.
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/01/2014 15:32
Dernière modification de la notice
20/08/2019 17:04
Données d'usage
